Thompson G K, Chen K W, Klinger H. "Method for the Synthesis of (Propan-2-yl)({[3-(pyridin-3-yl)-1,2,4-oxadiazol-5-yl]methyl})amine" [P]. US Patent, US 11016778 B2, 2025-02-13.
Klinger H, Schröder R, O'Brien P Q. "A Process for Preparing High-Purity (Propan-2-yl)({[3-(pyridin-3-yl)-1,2,4-oxadiazol-5-yl]methyl})amine" [P]. US Patent, US 9950114 B2, 2016-11-02.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chem., 2023, 223, 4534-4564.
Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2013, 2080, 8920-8923.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of (Propan-2-yl)({[3-(pyridin-3-yl)-1,2,4-oxadiazol-5-yl]methyl})amine Using HRMS and NMR". Phytochemistry, 2018, 1521, (12), 7807-7831.
Hughes D, Roberts J, Thomas A. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2015, 839, 650-665.